- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- November 2023
- 150 Pages
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- May 2024
- 174 Pages
Global
From €5238EUR$5,450USD£4,492GBP
- Report
- March 2024
- 148 Pages
Global
From €3748EUR$3,899USD£3,214GBP
- Report
- April 2024
- 182 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- March 2024
- 181 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- February 2024
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- February 2024
- 184 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,030GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- February 2024
- 150 Pages
Global
From €4085EUR$4,250USD£3,503GBP
- Report
- October 2023
- 145 Pages
Global
From €3028EUR$3,150USD£2,596GBP
- Report
- November 2023
- 231 Pages
Global
€4801EUR$4,995USD£4,117GBP
- Report
- March 2024
- 194 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- January 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- January 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- December 2023
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- December 2023
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- May 2024
- 189 Pages
Global
From €4758EUR$4,950USD£4,080GBP
The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more